24 results on '"Scheetz, Marc"'
Search Results
2. Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model
3. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation
4. Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity
5. Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
6. Does renal function matter for polymyxin B?
7. Vancomycin Area Under the Curve‐guided Dosing and Monitoring: “Is the Juice Worth the Squeeze”?
8. Clinical Guideline Highlights for the Hospitalist: Therapeutic Monitoring of Vancomycin
9. Supporting Precision Dosing in Drug Labeling
10. A Pharmacokinetics‐Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID‐19 Pandemic
11. Exploring the Relationship between FEV 1 Loss and Recovery and Aminoglycoside Pharmacokinetics in Adult Patients with Cystic Fibrosis: Implications for Clinical Dosing Strategies
12. Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention
13. Development of ELLA Approach to Measure Kidney Injury Molecule‐1
14. Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients
15. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation
16. Adherence to the 2009 Consensus Guidelines for Vancomycin Dosing and Monitoring Practices: A Cross-Sectional Survey of U.S. Hospitals
17. Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique
18. Antimicrobial Drug Shortages: A Crisis Amidst the Epidemic and the Need for Antimicrobial Stewardship Efforts to Lessen the Effects
19. Life‐Years Gained with Meropenem over Ciprofloxacin in Penicillin‐Allergic Patients with Gram‐Negative Bacilli Sepsis: Results of aP robabilistic Model
20. Differences in Clinical Outcomes in Patients with Vancomycin-Resistant Enterococci According to Linezolid Susceptibility
21. Predictability of Doripenem Susceptibility inAcinetobacter baumanniiIsolates Based on Other Carbapenem Susceptibilities andblaOXAGene Status
22. Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia
23. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin-induced kidney injury in a translational rat model.
24. Supporting Precision Dosing in Drug Labeling.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.